Peter Machmeier is a director in the Healthcare M&A Advisory practice, based in Minneapolis. Peter has over 10 years of experience advising publicly traded and privately held clients on buy- and sell-side M&A, capital raises, strategic options, valuations and other financial matters.
Peter’s healthcare experience covers a variety of areas, including aftermarket repair and maintenance services, contract development and manufacturing, medical devices and products, outsourced services and value-added distribution.
His recent engagements include advising Aterian Investment Partners on its acquisition of Allentown, LLC; the sale of SCR Medical Transportation to Beacon Mobility Corp., a portfolio company of Audax Private Equity; the sale of New Age Medical to Compass Group Equity Partners; the sale of eMindful to Wondr, a portfolio company of The Riverside Company; and the sale of Lab Products, a division of ShoreView Industries’ portfolio company Avidity Science, to Gen Cap America.
Prior to joining Kroll, Peter worked at Dougherty & Company, where he focused on capital raises, buy- and sell-side M&A, fairness opinions and valuations for middle-market clients, primarily within the healthcare industry.
Peter holds a BBA from the University of Wisconsin-Madison with a focus on finance, investments and banking. He is a FINRA Series 7, 63 and 79 registered representative.
Corporate Finance and Restructuring
Middle Market M&A, Strategic Advisory, Debt Advisory and Private Capital Markets, Restructuring and Insolvency Services, Financial Due Diligence, Fairness Opinions, Solvency Opinions and ESOP/ERISA Advisory
Healthcare Investment Banking
Healthcare expertise for middle-market M&A transactions. In 2018, Duff & Phelps acquired Kroll and unified under the Kroll brand in 2020.
Restaurant M&A Industry Insights – Winter 2023
Mar 15, 2023
by Robert A. Bartell, CFA, Josh Benn, Vijay Sampath, Howard P. Lanser, Jeremy Sacks, Josh Keatts